e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Immunology and genetics of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Design of immunogenic multiepitopic
mycobacterium tuberculosis
peptides from genes selected using
in vitro
models of mycobacterial macrophage infection
S. Contini, F. Seghrouchni, M. Bocchino, R. Markova, M. G. Alma, F. Mariani, M. Amicosante, C. Saltini (Rome, Naples, Italy; Sofia, Bulgaria)
Source:
Annual Congress 2007 - Immunology and genetics of tuberculosis
Session:
Immunology and genetics of tuberculosis
Session type:
Oral Presentation
Number:
2977
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Contini, F. Seghrouchni, M. Bocchino, R. Markova, M. G. Alma, F. Mariani, M. Amicosante, C. Saltini (Rome, Naples, Italy; Sofia, Bulgaria). Design of immunogenic multiepitopic
mycobacterium tuberculosis
peptides from genes selected using
in vitro
models of mycobacterial macrophage infection. Eur Respir J 2007; 30: Suppl. 51, 2977
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
Quantitative T-cell interferon-gamma responses to
Mycobacterium tuberculosis
-specific antigens in latent and active tuberculosis
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001
Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis
Source: Eur Respir J 2007; 29: 143-148
Year: 2007
Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Massive expansion of PPD-reactive CD4 T cells directed against a single peptide epitope from the
M. tuberculosis
ESAT-6 protein
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Genetically modified
Salmonella typhimurium
(ST) for the intranasal vaccination against
Mycobacterium tuberculosis
(Mtb):
In vitro
and
in vivo
results from the sequella vaccine
Source: Eur Respir J 2002; 20: Suppl. 38, 11s
Year: 2002
Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to
M. tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 363s
Year: 2006
Interferon-γ release assays using RD1 antigens in nontuberculous mycobacterial infections. A systematic review
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Deficient
in silico
selection of
mycobacterium tuberculosis
(MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
A pilot study of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of nontuberculous mycobacterial infections.
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Deficient
in silico
selection of
Mycobacterium tuberculosis
epitopes by an HLA susceptible allele
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection
Source: Eur Respir J 2010; 35: 619-626
Year: 2010
Humoral response to HspX and GlcB to previous and recent infection by
mycobacterium tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2010; 36: 355
Year: 2010
Evaluation of a IFN-γ test using
Mycobacterium tuberculosis
-specific antigens for diagnosis of active tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006
Characterization of the HBHA response in TB patients with or without HIV infection.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
IL-4 subverts mycobacterial containment in
Mycobacterium tuberculosis
-infected human macrophages
Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept